Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.60 |
| ▸ | GLA | P06280 | 4/20 | 0.60 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.60 |
| ▸ | GAA | P10253 | 3/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 1/20 | 0.60 |
| ▸ | POLB | P06746 | 1/20 | 0.60 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | ACHE | P22303 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.52 |
| ▸ | MAOA | P21397 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.47 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28854322 | 0.85 | ALDH1A1 (0.54) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL5387138 | 0.80 | ALDH1A1 (0.52) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL4299906 | 0.80 | ALDH1A1 (0.70) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL4014126 | 0.78 | KMT2A (0.64) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL28215732 | 0.77 | ALDH1A1 (0.49) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL27961721 | 0.77 | MAPT (0.59) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL11048480 | 0.77 | HTR3A (0.55) | ALDH1A1GLAKMT2AKDM4EGAA | |
| Acridine SCHEMBL27603600 | 0.77 | ALDH1A1 (0.94) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL17549872 | 0.76 | PDE3B (0.45) | ALDH1A1GLAKMT2AKDM4EGAA | |
| SCHEMBL30857473 | 0.76 | ALDH1A1 (0.64) | ALDH1A1GLAKMT2AKDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104327064-B | Acridine-1,3,4-oxadiazole compound having anti-tumor activity, preparation method and uses thereof | 广西中医药大学 | 2017-01-11 | — | — | CN | claimed |
| EP-0397474-A2 | Photosensitive composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-11-14 | — | — | EP | claimed |
| CN-111315828-B | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2023-09-29 | — | — | CN | disclosed |
| CN-112154167-B | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2023-08-22 | — | — | CN | disclosed |
| CN-110114376-B | Curable composition, method for producing cured product, cured product thereof, and adhesive using same | 株式会社ADEKA | 2022-06-14 | — | — | CN | disclosed |
| EP-3339331-B1 | COMPOSITION | ADEKA CORP (JP) | 2022-02-16 | — | — | EP | disclosed |
| CN-108419438-B | Coloring composition | 株式会社艾迪科 | 2021-10-01 | — | — | CN | disclosed |
| CN-112154167-A | Composition, cured product, optical filter, and method for producing cured product | 株式会社艾迪科 | 2020-12-29 | — | — | CN | disclosed |
| CN-111566173-A | Coating composition, method for curing the composition, barrier film, and method for producing cured product | 株式会社艾迪科 | 2020-08-21 | — | — | CN | disclosed |
| WO-2020021969-A1 | COMPOSITION, CURED PRODUCT, OPTICAL FILTER, AND PRODUCTION METHOD FOR CURED PRODUCT | 株式会社ADEKA | 2020-01-30 | — | — | WO | disclosed |
| CN-110114376-A | Curable composition, method for producing cured product, cured product thereof, and adhesive using same | 株式会社ADEKA | 2019-08-09 | — | — | CN | disclosed |
| EP-0397474-A2 | Photosensitive composition | KABUSHIKI KAISHA TOSHIBA (JP) | 1990-11-14 | — | — | EP | disclosed |
| US-4835312-A | Production process of N-substituted amide compounds | MITSUI CHEMICALS, INCORPORATED (JP) | 1989-05-30 | — | — | US | disclosed |
| EP-0073155-B1 | COMPOUNDS HAVING ANTITUMOUR ACTIVITY | WARNER-LAMBERT COMPANY (US) | 1986-10-29 | — | — | EP | disclosed |
| US-4537729-A | ANTITUMOR AGENTS | DEVELOPMENT OF FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1985-08-27 | — | — | US | disclosed |
| US-4479000-A | ANTITUMOR AGENTS | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1984-10-23 | — | — | US | disclosed |
| US-4472582-A | 3,5-Disubstituted-4'-(9-acridinylamino)-methane-sulfon-m-anisidide compounds having antitumor properties | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1984-09-18 | — | — | US | disclosed |
| EP-0025705-B1 | COMPOUNDS HAVING ANTITUMOUR PROPERTIES, PROCESS FOR THEIR PREPARATION, THESE COMPOUNDS FOR USE AS ANTITUMOUR AGENTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1983-06-22 | — | — | EP | disclosed |
| EP-0073155-A2 | Compounds having antitumour activity | WARNER-LAMBERT COMPANY (US) | 1983-03-02 | — | — | EP | disclosed |
| EP-0025705-A1 | Compounds having antitumour properties, process for their preparation, these compounds for use as antitumour agents and pharmaceutical compositions containing them | DEVELOPMENT FINANCE CORPORATION OF NEW ZEALAND (NZ) | 1981-03-25 | — | — | EP | disclosed |